Anthera Pharmaceuticals inks $25 million at-the-market equity offering

MLV & Co. will sell stock on a commercially reasonable efforts basis

By Devika Patel

Knoxville, Tenn., Nov. 8 - Anthera Pharmaceuticals, Inc. negotiated a $25 million at-the-market equity offering, according to a preliminary prospectus supplement filed Thursday with the Securities and Exchange Commission.

MLV & Co. LLC, the agent, will sell the stock on a commercially reasonable efforts basis.

Proceeds will be used for general corporate purposes.

Anthera, based in Hayward, Calif., is a biopharmaceutical company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.